TY - JOUR
T1 - Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection
AU - Yoshikai, Y.
PY - 2001/1/1
Y1 - 2001/1/1
N2 - Prostanoids, including prostaglandins and thromboxanes, are generated by the phospholipase A2/cyclooxygenase pathway, and leukotrienes are generated by the 5-lipoxygenase pathway from arachidonic acid. At physiological concentrations, vasodilator prostaglandins enhance the vascular permeability effects of histamine and bradykinin, and leukotrienes are important mediators of leukocyte accumulation during acute inflammation. On the other hand, prostaglandin metabolites such as cyclopentenone prostaglandins contribute to the resolution of acute inflammation through inhibition of nuclear factor-κB activation. Thus, arachidonic acid oxygenation products mediate diverse effects that induce and resolve acute inflammation caused by bacterial infection.
AB - Prostanoids, including prostaglandins and thromboxanes, are generated by the phospholipase A2/cyclooxygenase pathway, and leukotrienes are generated by the 5-lipoxygenase pathway from arachidonic acid. At physiological concentrations, vasodilator prostaglandins enhance the vascular permeability effects of histamine and bradykinin, and leukotrienes are important mediators of leukocyte accumulation during acute inflammation. On the other hand, prostaglandin metabolites such as cyclopentenone prostaglandins contribute to the resolution of acute inflammation through inhibition of nuclear factor-κB activation. Thus, arachidonic acid oxygenation products mediate diverse effects that induce and resolve acute inflammation caused by bacterial infection.
UR - http://www.scopus.com/inward/record.url?scp=0035001045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035001045&partnerID=8YFLogxK
U2 - 10.1097/00001432-200106000-00003
DO - 10.1097/00001432-200106000-00003
M3 - Review article
C2 - 11964841
AN - SCOPUS:0035001045
SN - 0951-7375
VL - 14
SP - 257
EP - 263
JO - Current Opinion in Infectious Diseases
JF - Current Opinion in Infectious Diseases
IS - 3
ER -